Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer

Cell Reports(2024)10.1016/j.celrep.2024.114176Source: DataRank Database

PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer is a research paper published in Cell Reports (2024). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

geo nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)OA: goldTopics (41)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Benjamín A. Colón-Emeric,Shigekazu Murakami,Mia N.Y. Shujath,Chunling Yi ORCID,Chan D.K. Nguyen

Live enrichment

PubMed:38691454 PMC:PMC11238875

NCI

Grant: T32CA009686

NCI

Grant: P30CA051008

NCI

Grant: R21CA258153

NCI

Grant: F31CA247417

NCI NIH HHS

Grant: R01 CA252223

National Institutes of Health

Grant: 5F31CA247417-02

Epigenetic mechanisms of gemcitabine resistance in pancreatic cancer

National Institutes of Health

Grant: 3T32CA009686-05S1

TRAINING GRANT IN TUMOR BIOLOGY

National Institutes of Health

Grant: 5R01CA252223-03

Mechanisms of Epigenetic Plasticity in PDAC

National Institutes of Health

Grant: 3P30CA051008-16S1

CANCER CENTER SUPPORT GRANT

National Institutes of Health

Grant: 1R21CA258153-01

An Inducible Model for Studying Cancer Stem Cells in PDAC

National Institutes of Health

goldLicense: cc-by-nc-nd

publisherhttp://www.cell.com/article/S2211124724005047/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124724005047?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124724005047?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11238875/pdf/nihms-2000714.pdf

repositoryhttps://doaj.org/article/f3dd5142fd7143d9862ebe27b62f2dc5

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Cell Line, TumorAnimalsHumansMiceCarcinoma, Pancreatic DuctalPancreatic NeoplasmsRepressor ProteinsDeoxycytidineEpigenesis, GeneticGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmProtein-Arginine N-MethyltransferasesCellular ReprogrammingGemcitabine

Keywords

Pancreatic cancerepigenetic reprogrammingBach1ChemoresistancePrmt1MaffCp: CancerProtein-Arginine N-MethyltransferasesQH301-705.5Cellular ReprogrammingGemcitabineDeoxycytidineArticleEpigenesis, GeneticPancreatic NeoplasmsRepressor ProteinsGene Expression Regulation, NeoplasticMiceDrug Resistance, NeoplasmCell Line, TumorHumansAnimalsBiology (General)Carcinoma, Pancreatic Ductal

Sustainable Development Goals

SDG 3: 3. Good health

PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer

FAIR Checklist

Authors (5)

Funding (11 grants)

Open Access

Topics

Annotations (Europe PMC)